This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Alternating Hemiplegia of Childhood Foundation, Cure Ahc, Inc., Hope for Annabel. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 1 Years Active: 2023
Title: Natalia Morsci: Innovator in Neurological Gene Therapy
Introduction
Natalia Morsci is a prominent inventor based in Salt Lake City, UT (US). She has made significant contributions to the field of gene therapy, particularly in the treatment of neurological disorders. Her innovative work focuses on the delivery of ATP1A3 genes to the central nervous system, which has the potential to transform therapeutic approaches for various neurological conditions.
Latest Patents
Natalia Morsci holds a patent for her invention titled "AAV-mediated delivery of ATP1A3 genes to central nervous system." This invention relates to a transgenic vector designed for transducing cells of a mammal's central nervous system (CNS) and transgenically expressing a protein within the CNS. The transgenic vector comprises a virus-derived vector, a nucleic acid sequence encoding the protein, and an endogenous ATP1A3 promoter sequence. Additionally, her invention includes a composition featuring a recombinant AAV vector that contains a nucleic acid sequence encoding an ATP1A3 protein, which is compatible with administration into the CNS. Furthermore, she has developed methods for treating subjects with neurological disorders associated with mutations in the ATP1A3 gene and for delivering transgenic ATP1A3 DNA to the CNS of mammals.
Career Highlights
Throughout her career, Natalia has worked with notable organizations such as Hope for Annabel and Cure AHC, Inc. Her dedication to advancing medical science through innovative solutions has established her as a key figure in her field.
Collaborations
Natalia has collaborated with esteemed colleagues, including Simon Frost and Neil Hackett. These partnerships have further enhanced her research and development efforts in gene therapy.
Conclusion
In summary, Natalia Morsci is a trailblazer in the field of neurological gene therapy, with a focus on innovative solutions for treating disorders linked to the ATP1A3 gene. Her contributions are paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile